Fluid and Neuroimaging Biomarkers in Microgliopathy Colony-Stimulating Factor-1 Receptor-Related Disorders
Tomasz Chmiela1,2, Madison Reeves3, Karen Jansen-West3
1Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
Plasma glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) show promise as biomarkers for detecting early-stage Colony-Stimulating Factor 1 Receptor-Related Disorders (CSF1R-RD) and monitoring disease progression.
Area of Science:
- Neuroscience
- Biomarker Discovery
- Genetics
Background:
- Colony-Stimulating Factor 1 Receptor-Related Disorders (CSF1R-RD) are rare genetic conditions.
- Identifying reliable biomarkers is crucial for early diagnosis and effective treatment monitoring.
Purpose of the Study:
- To identify fluid and neuroimaging biomarkers for CSF1R-RD.
- To inform optimal treatment timing and monitor disease progression.
Main Methods:
- Compared plasma and cerebrospinal fluid (CSF) biomarkers in asymptomatic carriers, symptomatic carriers, and healthy controls.
- Correlated biomarkers with clinical scales (MoCA, CCSS) and cortical thickness via MRI.
Main Results:
- Plasma GFAP effectively distinguishes early-stage CSF1R-RD patients from controls.
- Plasma NfL is more sensitive for tracking disease progression after symptom onset.
Conclusions:
- Plasma NfL and GFAP are valuable biomarkers for early symptom onset and disease progression in CSF1R-RD.
- These biomarkers can aid in clinical management and therapeutic strategies.
More Related Videos
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
08:22Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
Related Concept Videos
Amebiasis
Encephalitis ll: Pathophysiology
